PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea · Delayed Price · Currency is KRW

349,500

0.00 (0.00%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Pharmaceuticals	350.12B	261.01B	194.76B	154.08B	108.75B
Pharmaceuticals Growth	34.14%	34.02%	26.40%	41.69%	29.66%
Total	350.12B	261.01B	194.76B	154.08B	108.75B
Total Growth	34.14%	34.02%	26.40%	41.69%	29.66%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
South Korea	219.75B	170.07B	138.65B	111.60B	83.64B
South Korea Growth	29.21%	22.66%	24.25%	33.42%	26.67%
Overseas	130.37B	90.94B	56.10B	42.49B	25.10B
Overseas Growth	43.36%	62.09%	32.05%	69.24%	40.71%
Total	350.12B	261.01B	194.76B	154.08B	108.75B
Total Growth	34.14%	34.02%	26.40%	41.69%	29.66%

Source: S&P Global Market Intelligence.